Track topics on Twitter Track topics that are important to you
NEW YORK, June 09, 2015 (GLOBE NEWSWIRE) -- Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, continues its support of innovation in the sciences by speaking at this year’s ILSI Health and Environmental Sciences Institute (“HESI”) Annual Meeting in Washington, DC. HESI’s mission is to engage scientists in academia, government, industry, research institutes and NGOs to identify and resolve global health and environmental issues. Misti Ushio, Ph.D., managing director and chief strategy officer at Harris & Harris Group, will lead a talk titled, “Investing in Innovation,” Tuesday June 9th at 5:00 pm.
Dr. Ushio will be speaking to professionals from academia, government, NGOs, and from the pharmaceutical, chemical and life science industries. The audience and discussion parallel Harris & Harris Group’s investment focus in BIOLOGY+. BIOLOGY+ describes the firm’s investment strategy in life science companies where biology intersects with innovations in technology areas such as electronics, physics, materials science, chemistry, information technology, engineering and mathematics.
“At Harris & Harris Group we continually look for the next technology trends. I am excited to share my thoughts on what the future of science looks likes today and what exciting technology is around the corner,” said Dr. Ushio. “Finding a new, innovative technology is one thing, but knowing how to shepherd that technology into commercialization is an even greater challenge. I am eager to share with the HESI audience the ecosystem that we engage with in order to make launching these technologies successful.”
The HESI Annual Meeting will be taking place June 9th-12th in Washington, DC, at the Westin Georgetown. For a full agenda with topics and speaker information please visit: http://bit.ly/1dk3WWU.
About Harris & Harris Group
Harris & Harris Group, Inc. is a publicly traded venture capital firm that is also a business development company. Detailed information about Harris & Harris Group and its holdings can be found on its website at www.HHVC.com and by following on Facebook at www.facebook.com/harrisharrisvc and on Twitter @harrisandharrisgroup.
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2014, as well as subsequent filings, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including, but not limited to, the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The references to the websites www.HHVC.com and www.Facebook.com have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Harris & Harris Group is not responsible for the contents of third party websites.
Press contact Jessica Attanasio Associate Vice President Gregory FCA Jessica@GregoryFCA.com 610-228-2112NEXT ARTICLE
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...